THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA
1 total filings · 0 classes · Active since Sep 2005
THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 36 (Insurance & Finance) with 1 filings. The WikiTrademarks Expansion Score is 1/100, low — the brand is focused on defending its existing categories rather than expanding.
USPTO data refreshed October 27, 2026
Protect or track "THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA"
Watch this name and we'll alert you when anyone files a similar mark.
Informational only, not a legal opinion. Consult a trademark attorney before filing or enforcing.
Own this brand? Claim the profile to add your logo, story, and website.
Sign in to claimHow is THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA filing trademarks, and where is the portfolio expanding?
Filing Velocity (24 Months)
Nice Class Distribution
Activity Timeline
No activity recorded yet.
Recent Filings
| Serial No. | Mark | Filing Date | Status | Classes | Owner |
|---|---|---|---|---|---|
| 79016495 | THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA | Sep 05, 2005 | Pending | 036 Insurance & Finance | The Global Fund to fight Aids, Tuberculosis and Malaria |
Weekly visibility reports showing how ChatGPT mentions THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA, where you rank in the answer, the sentiment of the mention, and which sources ChatGPT cites.
FAQ: THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA trademark portfolio
What trademarks does THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA hold?
THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 36 (Insurance & Finance). The most recent filings are registered to The Global Fund to fight Aids, Tuberculosis and Malaria.
How many trademarks does THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA have at the USPTO?
WikiTrademarks tracks 1 USPTO trademark filings attributed to THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA. The brand has been actively filing since September 2005. The count updates daily as new filings are indexed from the USPTO bulk data feed.
In which NICE classes does THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA file most often?
THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA's most active class is NICE Class 36 (Insurance & Finance), with 1 filings. The full distribution across all 0 classes is shown in the Nice Class Distribution panel on this page.
Who owns the THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA trademark?
The most recent filings under the THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA mark are registered to The Global Fund to fight Aids, Tuberculosis and Malaria. Trademark ownership can shift through assignments — see the Ownership & Assignment History section on this page for the full chain of title.
Is THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA expanding into new categories?
The current WikiTrademarks Expansion Score for THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA is 1 out of 100, which is low — the brand is focused on defending its existing categories rather than expanding. The score combines NICE class breadth, filing velocity, and the rate of cross-class movement from the brand's filing history.
How can I track new THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA trademark filings?
Click the Watch Brand button at the top of this page to add THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA to your Watchlist. New filings show up on your WikiTrademarks dashboard within 24 to 48 hours of being public, alongside any class expansions, status changes, or assignment events.
More on this portfolio: Compare THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA to another owner · Browse all NICE classes · Most valuable brands
Community notes
0 notesShare what you know about THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA and help the next person researching it.